Expression of vascular endothelial growth factor in sera and lymph nodes of the plasma cell type of Castleman's disease

British Journal of Haematology

Volumn 104, Issue 3, 1999, Pages 482-485

  Nishi, Jun Ichiro ^a,b   Arimura, Kimiyoshi ^a   Utsunomiya, Atae ^c   Yonezawa, Suguru ^a   Kawakami, Kiyoshi ^a   Maeno, Nobuaki ^a   Ijichi, Osamu ^a   Ikarimoto, Naoaki ^a   Nakata, Masanori ^a   Kitajima, Isao ^a   Fukushige, Takahiko ^b   Takamatsu, Hideo ^b   Miyata, Koichiro ^a   Maruyama, Ikuro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c Imamura Bun in Hospital   (Japan)

Author keywords

Castleman's disease; Lymph node; Plasma cell type; Vascular endothelial growth factor; Vascular proliferation

Indexed keywords

VASCULOTROPIN;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULAR ENDOTHELIUM;

EID: 0033061386     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01208.x     Document Type: Article

References (17)

1. Adelman, H.M., Cacciatore, M.L., Pascual, J.F., Mike, J.M., Alberts, W.M. & Wallach, P.M. (1994) Castleman disease in association with POEMS. American Journal of the Medical Sciences, 307, 112-114.
2. Castleman, B., Iverson, L. & Menendez, V.P. (1956) Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer. 9, 822-830.
3. Cohen, T., Nahari, D., Cerem, L.W., Neufeld, G. & Levi, B.Z. (1996) Interleukin 6 induces the expression of vascular endothelial growth factor. Journal of Biological Chemistry. 271, 736-741.
4. Foss, H.D., Araujo, I., Demel, G., Klotzbach, H., Hummel, M. & Stein, H. (1997) Expression of vascular endothelial growth factor in lymphomas and Castleman's disease. Journal of Pathology, 183, 44-50.
5. Gaba, A.R., Stein, R.S., Sweet, D.L. & Variakojis, D. (1978) Multicentric giant lymph node hyperplasia. American Journal of Clinical Pathology, 69, 86-90.
6. Gherardi, R.K., Belec, L., Fromont, G., Divine, M., Malapert, D., Gaulard, P. & Degos, J.D. (1994) Elevated levels of interleukin-1 beta (IL-1 beta) and IL-6 in serum and increased production of IL-1 beta mRNA in lymph nodes of patients with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes (POEMS) syndrome. Blood, 83, 2587-2593.
7. Gherardi, R.K., Malapert, D. & Degos, J.D. (1991) Castleman disease-POEMS syndrome overlap. Annals of Internal Medicine, 114, 520-521.
8. Hanatani, M., Tanaka, Y., Kondo, S., Ohmori, I. & Suzuki, H. (1995) Sensitive chemiluminescence enzyme immunoassay for vascular endothelial growth factor/vascular permeability factor in human serum. Bioscience Biotechnology and Biochemistry. 59, 1958-1959.
9. Herrada, J. & Cabanillas, F.F. (1995) Multicentric Castleman's disease. American Journal of Clinical Oncology. 18, 180-183.
10. Keller, A.R., Hochholzer, L. & Castleman, B. (1972) Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer, 29, 670-683.
11. Lesprit, P., Godeau, B., Authier, F.J., Soubrier, M., Zuber, M., Larroche, C., Viard, J.P., Wechsler, B. & Gherardi, R. (1998) Pulmonary hypertension in POEMS syndrome: a new feature mediated by cytokines. American Journal of Respiratory Critical Care Medicine, 157, 907-911.
12. Mandler, R.N., Kerrigan, D.P., Smart, J., Kuis, W., Villiger, P. & Lotz, M. (1992) Castleman's disease in POEMS syndrome with elevated interleukin-6. Cancer, 69, 2697-2703.
13. Watanabe, O., Arimura, K., Kitajima, I., Osame, M. & Maruyama, I. (1996) Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet, 347, 702.
14. Watanabe, O., Maruyama, I., Arimura, K., Kitajima, I., Arimura, H., Hanatani, M., Matsuo, K., Arisato, T. & Osame, M. (1998) Overproduction of vascular endothelial growth factor (VEGF/VPF) is causative in POEMS syndrome. Muscle and Nerve 21, 1390-1397.
15. Weisenburger, D.D., Nathwani, B.N., Winberg, C.D. & Rappaport, H. (1985) Multicentric angiofollicular lymph node hyperplasia: a clinicopathologic study of 16 cases. Human Pathology, 16, 162-172.
16. Winter, S.S., Howard, T.A., Ritchey, A.K., Keller, F.G. & Ware, R.E. (1996) Elevated levels of tumor necrosis factor-beta, gamma-interferon, and IL-6 mRNA in Castleman's disease. Medical and Pediatric Oncology, 26, 48-53.
17. Yoshizaki, K., Matsuda, T., Nishimoto N., Kuritani, T., Taeho, L., Aozasa, K., Nakahata, T., Kawai, H., Tagoh, H., Komori, T., Kishimoto, S., Hirano, T. & Kishimoto, T. (1989) Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood, 74, 1360-1367.